aTyr Pharma, Inc. share price logo

aTyr Pharma, Inc.

NASDAQ: ATYR

Small Cap

$1.02

+0.18

(+21.71%)

as on

aTyr Pharma, Inc. Stock Performance

as on May 7, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.84
    $1.04
    downward going graph

    17.65%

    Downside

    1.96%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.64
    $7.29
    downward going graph

    37.25%

    Downside

    614.75%

    Upside

    downward going graph

aTyr Pharma, Inc. share price movements today

Previous Close
$0.84
Open
$0.84
Volume
4.8M
Day's Low - High
$0.84 - $1.04
52 Week Low - High
$0.64 - $7.29

aTyr Pharma, Inc. Historical Returns

1 Month Return
+ 2.21 %
3 Month Return
-6.32 %
1 Year Return
-73.93 %
3 Year Return
0 %
5 Year Return
0 %

aTyr Pharma, Inc. Stock Fundamentals & Key Indicators

Check aTyr Pharma, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$82.6M

EPS (TTM)

-0.6025

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-108.11%

aTyr Pharma, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of aTyr Pharma, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
aTyr Pharma, Inc. image
aTyr Pharma, Inc.
NA$82.6MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$40.2B127.94%75.8512.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$107.9B99.08%25.1832.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.1BNA120.445.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$73.6B40.83%17.1329.65%

Stock Returns calculator for aTyr Pharma, Inc. Stock including INR - Dollar returns

The aTyr Pharma, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

aTyr Pharma, Inc. investment value today

Current value as on today

₹35,439

Returns

-₹64,561

(-64.56%)

Returns from aTyr Pharma, Inc. Stock

-₹68,421 (-68.42%)

Dollar Impact

₹3,860 (+3.86%)

aTyr Pharma, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
-
0
-
-
-
-
-
0
-
Gross Profit
0
0
0
0
0
-12
0
0
-21
0
Operating Income
-12
-15
-16
-17
-18
-15
-15
-20
-26
-14
EBITDA
-11
-15
-15
-16
-17
-15
-15
-19
-25
-14
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-14
-15
-16
-17
-14
-14
-19
-25
-13
Income Tax Expense
0
0
0
0
-
-
-
-
-
-
Net Income
-11
-14
-15
-16
-17
-14
-14
-19
-25
-13
Net Profit Margin
-3212.46%
0.00%
-6591.91%
0.00%
0.00%
0.00%
0.00%
0.00%
-13549.47%
0.00%

aTyr Pharma, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
10
-
10
0
0
0
Gross Profit
-13
-6
-1
8
0
0
-1
Operating Income
-22
-15
-34
-46
-54
-67
-77
EBITDA
-22
-14
-32
-44
-52
-66
-76
Interest Expense
-
-
-
-
-
-
-
Depreciation
-
1
1
1
2
1
1
Income Before Tax
-23
-16
-33
-45
-50
-64
-74
Income Tax Expense
0
0
0
0
0
-
-
Net Income
-23
-16
-33
-45
-50
-64
-74
Net Profit Margin
-5593.13%
-155.18%
0.00%
-436.53%
-14274.50%
-27243.83%
-39009.47%

aTyr Pharma, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-14
-15
-16
-17
-14
-14
-19
-25
-13
Operating Cash Flow
-11
-22
-20
-13
-13
-15
-13
-20
-12
Investing Cash Flow
17
-1
6
17
-6
-4
3
-20
16
Financing Cash Flow
6
7
13
0
18
18
17
29
0
Change in Cash
12
-15
0
4
0
-1
7
-11
4

aTyr Pharma, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-48
-34
-23
-16
-33
-45
-50
-64
-74
Operating Cash Flow
-42
-31
-20
-15
-33
-41
-33
-69
-61
Investing Cash Flow
-27
37
4
6
-91
47
-20
17
-5
Financing Cash Flow
52
-4
1
16
110
5
66
39
66
Change in Cash
-17
1
-13
7
-14
10
12
-12
-1

aTyr Pharma, Inc. News & Key Events

  • img

    Today's Timeline - 15 September

    Mon, 08:28 PM

    -

    Atyr Pharma stock plummets 80.76% after Phase 3 trial fails primary endpoint for efzofitimod in pulmonary sarcoidosis.

Insights on aTyr Pharma, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, BeOne Medicines Ltd has given 28.1% return, outperforming this stock by 101.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, ATYR stock has moved down by -73.3%

About aTyr Pharma, Inc.

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs); and treatment of other ILDs, such as chronic hypersensitivity pneumonitis (CHP) and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
OrganisationaTyr Pharma, Inc.
Headquarters10240 Sorrento Valley Road, San Diego, CA, United States, 92121
IndustryBiotechnology
CEODr. Sanjay S. Shukla M.D., M.S.
E-voting on sharesClick here to vote

Key Management of aTyr Pharma, Inc.

Name

Title

Ms. Danielle Campbell

VP of Human Resource

Ms. Dalia R. Rayes M.B.A.

Head of Commercial, Global Efzofitimod Franchise

Dr. Leslie Nangle Ph.D.

Vice President of Research

Dr. Sanjay S. Shukla M.D., M.S.

President, CEO & Director

Ms. Nancy E. Denyes Krueger J.D.

General Counsel & Corporate Secretary

Ms. Ashlee Dunston

Director of Investor Relations & Corporate Communications

Mr. Peter Villiger

Vice President of Corporate Development

FAQs

What is aTyr Pharma, Inc. share price today?

aTyr Pharma, Inc. share price today is $1.02 as on at the close of the market. aTyr Pharma, Inc. share today touched a day high of $1.04 and a low of $0.84.

What is the 52 week high and 52 week low for aTyr Pharma, Inc. share?

aTyr Pharma, Inc. share touched a 52 week high of $7.29 on and a 52 week low of $0.64 on . aTyr Pharma, Inc. stock price today i.e. is closed at $1.02,which is 86.01% down from its 52 week high and 59.38% up from its 52 week low.

What is aTyr Pharma, Inc.'s market capitalisation today?

aTyr Pharma, Inc. market capitalisation is $0.00T as on .

How to invest in aTyr Pharma, Inc. Stock (ATYR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for aTyr Pharma, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in aTyr Pharma, Inc. Shares that will get you 1.4706 shares as per aTyr Pharma, Inc. share price of $1.02 per share as on May 7, 2026 at 1:29 am IST.

What is the minimum amount required to buy aTyr Pharma, Inc. Stock (ATYR) from India?

Indian investors can start investing in aTyr Pharma, Inc. (ATYR) shares with as little as ₹94.61 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in aTyr Pharma, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on aTyr Pharma, Inc. share’s latest price of $1.02 as on May 7, 2026 at 1:29 am IST, you will get 9.8039 shares of aTyr Pharma, Inc.. Learn more about fractional shares .